Janney Montgomery Scott LLC Catalent, Inc. Transaction History

Janney Montgomery Scott LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$31.86 - $67.26 $505,299 - $1.07 Million	15,860 Added 102.65%	31,311 $1.36 Million
Q1 2023 Apr 28, 2023	BUY	$45.44 - $74.26 $702,093 - $1.15 Million	15,451 New	15,451 $1.02 Million
Q2 2022 Aug 03, 2022	SELL	$87.2 - $114.05 $322,901 - $422,327	-3,703 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$94.19 - $124.49 $164,832 - $217,857	-1,750 Reduced 32.09%	3,703 $411,000
Q4 2021 Jan 27, 2022	BUY	$119.57 - $139.07 $211,758 - $246,292	1,771 Added 48.1%	5,453 $698,000
Q3 2021 Oct 29, 2021	SELL	$109.17 - $142.35 $373,143 - $486,552	-3,418 Reduced 48.14%	3,682 $490,000
Q2 2021 Jul 26, 2021	BUY	$100.34 - $115.69 $146,496 - $168,907	1,460 Added 25.89%	7,100 $768,000
Q1 2021 Apr 27, 2021	BUY	$101.51 - $125.27 $1,319 - $1,628	13 Added 0.23%	5,640 $594,000
Q4 2020 Jan 25, 2021	BUY	$85.88 - $105.36 $483,246 - $592,860	5,627 New	5,627 $586,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.